474125-09-2Relevant articles and documents
8-Methoxyquinolines as PDE4 inhibitors.
Billah, Motasim,Buckley, George M,Cooper, Nicola,Dyke, Hazel J,Egan, Robert,Ganguly, Ashit,Gowers, Lewis,Haughan, Alan F,Kendall, Hannah J,Lowe, Christopher,Minnicozzi, Michael,Montana, John G,Oxford, Janet,Peake, Joanna C,Picken, C Louise,Piwinski, John J,Naylor, Robert,Sabin, Verity,Shih, Neng-Yang,Warneck, Julie B H
, p. 1617 - 1619 (2002)
The synthesis and pharmacological profile of a novel series of 2-substituted 8-methoxyquinolines is described. The 2-trifluoromethyl compound was found to be a potent inhibitor of phosphodiesterase type 4 (PDE4).
PYRAZOLONE DERIVATIVE AND PDE INHIBITOR CONTAINING THE SAME AS ACTIVE INGREDIENT
-
Page/Page column 59, (2010/04/25)
It is to provide a novel pyrazolone derivative represented by the following general formula (1), which is useful as a pharmaceutical and has a phosphodiesterase inhibitory action: wherein R1,R2: C1-6 alkyl; R3,R4: H, X, C1-6 alkoxy; Z:O, S; A:AA, BB, wherein AA represents wherein BB represents wherein R5: H, C1-6 alkyl ; R6,R7: C1-6 alkyl.